Published in J Virol on June 01, 2006
Influenza virus M2 protein mediates ESCRT-independent membrane scission. Cell (2010) 4.33
Influenza virus assembly and budding. Virology (2011) 2.90
Influenza virus hemagglutinin and neuraminidase, but not the matrix protein, are required for assembly and budding of plasmid-derived virus-like particles. J Virol (2007) 2.82
High level of genetic compatibility between swine-origin H1N1 and highly pathogenic avian H5N1 influenza viruses. J Virol (2010) 2.29
Cellular networks involved in the influenza virus life cycle. Cell Host Microbe (2010) 2.23
The influenza virus M2 protein cytoplasmic tail interacts with the M1 protein and influences virus assembly at the site of virus budding. J Virol (2008) 2.12
Mutational analysis of cis-acting RNA signals in segment 7 of influenza A virus. J Virol (2008) 2.10
Influenza virus morphogenesis and budding. Virus Res (2009) 2.07
Identification of the domains of the influenza A virus M1 matrix protein required for NP binding, oligomerization and incorporation into virions. J Gen Virol (2007) 1.83
Universal M2 ectodomain-based influenza A vaccines: preclinical and clinical developments. Expert Rev Vaccines (2009) 1.83
A LC3-interacting motif in the influenza A virus M2 protein is required to subvert autophagy and maintain virion stability. Cell Host Microbe (2014) 1.76
Influenza virus m2 ion channel protein is necessary for filamentous virion formation. J Virol (2010) 1.73
Viroporins: structure and biological functions. Nat Rev Microbiol (2012) 1.56
Identification of a novel splice variant form of the influenza A virus M2 ion channel with an antigenically distinct ectodomain. PLoS Pathog (2012) 1.55
At the centre: influenza A virus ribonucleoproteins. Nat Rev Microbiol (2014) 1.33
Nucleotide sequence requirements at the 5' end of the influenza A virus M RNA segment for efficient virus replication. J Virol (2009) 1.26
The lack of an inherent membrane targeting signal is responsible for the failure of the matrix (M1) protein of influenza A virus to bud into virus-like particles. J Virol (2010) 1.25
Colocalization of different influenza viral RNA segments in the cytoplasm before viral budding as shown by single-molecule sensitivity FISH analysis. PLoS Pathog (2013) 1.23
Novel approach to the development of effective H5N1 influenza A virus vaccines: use of M2 cytoplasmic tail mutants. J Virol (2007) 1.20
The cytoplasmic tail of the human respiratory syncytial virus F protein plays critical roles in cellular localization of the F protein and infectious progeny production. J Virol (2006) 1.20
Influenza A: understanding the viral life cycle. Yale J Biol Med (2009) 1.17
Influenza A virus lacking M2 protein as a live attenuated vaccine. J Virol (2009) 1.16
Novel vaccines against influenza viruses. Virus Res (2011) 1.04
Filamentous influenza virus enters cells via macropinocytosis. J Virol (2012) 1.02
Overlapping roles of the Rous sarcoma virus Gag p10 domain in nuclear export and virion core morphology. J Virol (2007) 1.00
Palmitoylation of the influenza A virus M2 protein is not required for virus replication in vitro but contributes to virus virulence. J Virol (2009) 1.00
Tyrosines in the influenza A virus M2 protein cytoplasmic tail are critical for production of infectious virus particles. J Virol (2010) 0.99
Studies of an influenza A virus temperature-sensitive mutant identify a late role for NP in the formation of infectious virions. J Virol (2008) 0.97
The amphipathic helix of influenza A virus M2 protein is required for filamentous bud formation and scission of filamentous and spherical particles. J Virol (2013) 0.95
Native morphology of influenza virions. Front Microbiol (2012) 0.95
Conformational analysis of the full-length M2 protein of the influenza A virus using solid-state NMR. Protein Sci (2013) 0.94
Cytoplasmic domain of influenza B virus BM2 protein plays critical roles in production of infectious virus. J Virol (2007) 0.94
Reassortment between seasonal and swine-origin H1N1 influenza viruses generates viruses with enhanced growth capability in cell culture. Virus Res (2010) 0.93
Virus-like particles as universal influenza vaccines. Expert Rev Vaccines (2012) 0.93
The cholesterol recognition/interaction amino acid consensus motif of the influenza A virus M2 protein is not required for virus replication but contributes to virulence. Virology (2010) 0.91
Specific residues in the 2009 H1N1 swine-origin influenza matrix protein influence virion morphology and efficiency of viral spread in vitro. PLoS One (2012) 0.90
Structural Analysis of the Roles of Influenza A Virus Membrane-Associated Proteins in Assembly and Morphology. J Virol (2015) 0.88
Human annexin A6 interacts with influenza a virus protein M2 and negatively modulates infection. J Virol (2011) 0.88
Extending the cytoplasmic tail of the influenza a virus M2 protein leads to reduced virus replication in vivo but not in vitro. J Virol (2007) 0.87
Influenza virus pathogenicity is determined by caspase cleavage motifs located in the viral proteins. J Mol Genet Med (2009) 0.87
Ultracentrifugation deforms unfixed influenza A virions. J Gen Virol (2011) 0.86
Mutations in the membrane-proximal region of the influenza A virus M2 protein cytoplasmic tail have modest effects on virus replication. J Virol (2011) 0.85
Structure-based design of NS2 mutants for attenuated influenza A virus vaccines. Virus Res (2010) 0.85
Free-energy profiles for ions in the influenza M2-TMD channel. Proteins (2009) 0.85
Specific nucleoprotein residues affect influenza virus morphology. J Virol (2013) 0.84
Development of live-attenuated influenza vaccines against outbreaks of H5N1 influenza. Viruses (2012) 0.82
Caveolin-1 influences human influenza A virus (H1N1) multiplication in cell culture. Virol J (2010) 0.82
Role of the CM2 protein in the influenza C virus replication cycle. J Virol (2010) 0.81
Influenza virus M2 protein ion channel activity helps to maintain pandemic 2009 H1N1 virus hemagglutinin fusion competence during transport to the cell surface. J Virol (2014) 0.80
Chemical ligation of the influenza M2 protein for solid-state NMR characterization of the cytoplasmic domain. Protein Sci (2015) 0.79
Coronavirus envelope (E) protein remains at the site of assembly. Virology (2015) 0.79
Cholesterol-Dependent Conformational Exchange of the C-Terminal Domain of the Influenza A M2 Protein. Biochemistry (2015) 0.78
The nucleoprotein and matrix protein segments of H5N1 influenza viruses are responsible for dominance in embryonated eggs. J Gen Virol (2011) 0.78
An M2 cytoplasmic tail mutant as a live attenuated influenza vaccine against pandemic (H1N1) 2009 influenza virus. Vaccine (2011) 0.78
Hepatitis E virus ORF3 is a functional ion channel required for release of infectious particles. Proc Natl Acad Sci U S A (2017) 0.76
Detection of proton movement directly across viral membranes to identify novel influenza virus M2 inhibitors. J Virol (2013) 0.76
NB protein does not affect influenza B virus replication in vitro and is not required for replication in or transmission between ferrets. J Gen Virol (2015) 0.75
Host cellular protein TRAPPC6AΔ interacts with influenza A virus M2 protein and regulates viral propagation by modulating M2 trafficking. J Virol (2016) 0.75
M2SR, a novel live single replication influenza virus vaccine, provides effective heterosubtypic protection in mice. Vaccine (2016) 0.75
Lateral Organization of Influenza Virus Proteins in the Budozone Region of the Plasma Membrane. J Virol (2017) 0.75
Cell Cycle-independent Role of Cyclin D3 in Host Restriction of Influenza Virus Infection. J Biol Chem (2017) 0.75
The M2 protein of live, attenuated influenza vaccine encodes a mutation that reduces replication in human nasal epithelial cells. Vaccine (2017) 0.75
Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene (1991) 38.64
Genetic applications of an inverse polymerase chain reaction. Genetics (1988) 18.48
Generation of influenza A viruses entirely from cloned cDNAs. Proc Natl Acad Sci U S A (1999) 14.90
Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol Cell Biol (1987) 11.36
Influenza virus M2 protein has ion channel activity. Cell (1992) 8.52
Influenza A virus M2 protein: monoclonal antibody restriction of virus growth and detection of M2 in virions. J Virol (1988) 5.31
Ebola virus VP40 drives the formation of virus-like filamentous particles along with GP. J Virol (2002) 3.62
Influenza virus hemagglutinin and neuraminidase cytoplasmic tails control particle shape. EMBO J (1997) 3.23
Influenza a virus M2 ion channel activity is essential for efficient replication in tissue culture. J Virol (2002) 2.97
Influenza virus assembly: effect of influenza virus glycoproteins on the membrane association of M1 protein. J Virol (2000) 2.94
Assembly and budding of influenza virus. Virus Res (2004) 2.90
Influenza virus hemagglutinin concentrates in lipid raft microdomains for efficient viral fusion. Proc Natl Acad Sci U S A (2003) 2.83
Influenza virus hemagglutinin and neuraminidase glycoproteins stimulate the membrane association of the matrix protein. J Virol (1996) 2.30
The influenza A virus M2 cytoplasmic tail is required for infectious virus production and efficient genome packaging. J Virol (2005) 2.23
Transmembrane domain of influenza virus neuraminidase, a type II protein, possesses an apical sorting signal in polarized MDCK cells. J Virol (1996) 1.95
Association of influenza virus matrix protein with ribonucleoproteins. J Virol (1999) 1.95
Reverse genetics studies on the filamentous morphology of influenza A virus. J Gen Virol (2003) 1.92
Effect of cytoplasmic tail truncations on the activity of the M(2) ion channel of influenza A virus. J Virol (1999) 1.87
Influenza B virus BM2 protein has ion channel activity that conducts protons across membranes. Dev Cell (2003) 1.77
In vitro dissection of the membrane and RNP binding activities of influenza virus M1 protein. Virology (2001) 1.70
Growth restriction of influenza A virus by M2 protein antibody is genetically linked to the M1 protein. Proc Natl Acad Sci U S A (1989) 1.69
Reverse genetics system for generation of an influenza A virus mutant containing a deletion of the carboxyl-terminal residue of M2 protein. J Virol (1995) 1.68
Membrane interaction of influenza virus M1 protein. Virology (2000) 1.63
Influenza A virus can undergo multiple cycles of replication without M2 ion channel activity. J Virol (2001) 1.63
The cytoplasmic tails of the influenza virus spike glycoproteins are required for normal genome packaging. Virology (2000) 1.61
The influenza virus ion channel and maturation cofactor M2 is a cholesterol-binding protein. Eur Biophys J (2004) 1.54
Lipid raft-dependent targeting of the influenza A virus nucleoprotein to the apical plasma membrane. Traffic (2004) 1.53
Role of transmembrane domain and cytoplasmic tail amino acid sequences of influenza a virus neuraminidase in raft association and virus budding. J Virol (2004) 1.46
Influenza B virus BM2 protein is a crucial component for incorporation of viral ribonucleoprotein complex into virions during virus assembly. J Virol (2004) 1.19
Influenza B virus requires BM2 protein for replication. J Virol (2004) 1.08
Role of the M2 protein in influenza virus membrane fusion: effects of amantadine and monensin on fusion kinetics. Virology (1993) 1.03
Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy (2007) 20.92
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature (2009) 14.59
Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. Nature (2012) 14.17
Dissection of the autophagosome maturation process by a novel reporter protein, tandem fluorescent-tagged LC3. Autophagy (2007) 11.74
Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production. Nature (2008) 11.39
Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature (2009) 11.34
Avian flu: influenza virus receptors in the human airway. Nature (2006) 11.28
Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature (2007) 10.40
Resistant influenza A viruses in children treated with oseltamivir: descriptive study. Lancet (2004) 8.62
A subdomain of the endoplasmic reticulum forms a cradle for autophagosome formation. Nat Cell Biol (2009) 7.84
Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors. Nature (2006) 7.56
Two Beclin 1-binding proteins, Atg14L and Rubicon, reciprocally regulate autophagy at different stages. Nat Cell Biol (2009) 7.35
The Atg16L complex specifies the site of LC3 lipidation for membrane biogenesis in autophagy. Mol Biol Cell (2008) 6.66
Avian flu: isolation of drug-resistant H5N1 virus. Nature (2005) 6.66
Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus. Nature (2004) 6.11
PB2 amino acid at position 627 affects replicative efficiency, but not cell tropism, of Hong Kong H5N1 influenza A viruses in mice. Virology (2004) 5.96
Influenza: lessons from past pandemics, warnings from current incidents. Nat Rev Microbiol (2005) 5.28
Properties and dissemination of H5N1 viruses isolated during an influenza outbreak in migratory waterfowl in western China. J Virol (2006) 5.26
Architecture of ribonucleoprotein complexes in influenza A virus particles. Nature (2006) 4.52
Growth of H5N1 influenza A viruses in the upper respiratory tracts of mice. PLoS Pathog (2007) 4.49
Atg9a controls dsDNA-driven dynamic translocation of STING and the innate immune response. Proc Natl Acad Sci U S A (2009) 4.48
Autophagosomes form at ER-mitochondria contact sites. Nature (2013) 4.32
Single-reaction genomic amplification accelerates sequencing and vaccine production for classical and Swine origin human influenza a viruses. J Virol (2009) 4.20
Drosophila RNAi screen identifies host genes important for influenza virus replication. Nature (2008) 4.18
An Atg4B mutant hampers the lipidation of LC3 paralogues and causes defects in autophagosome closure. Mol Biol Cell (2008) 4.00
Inhibition of Lassa and Marburg virus production by tetherin. J Virol (2008) 3.98
Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations. Arch Virol (2010) 3.77
Characterization of H7N9 influenza A viruses isolated from humans. Nature (2013) 3.71
Gain-of-function experiments on H7N9. Science (2013) 3.67
Biological and structural characterization of a host-adapting amino acid in influenza virus. PLoS Pathog (2010) 3.65
Ebola virus VP40 drives the formation of virus-like filamentous particles along with GP. J Virol (2002) 3.62
The potential for respiratory droplet-transmissible A/H5N1 influenza virus to evolve in a mammalian host. Science (2012) 3.50
Leaf senescence and starvation-induced chlorosis are accelerated by the disruption of an Arabidopsis autophagy gene. Plant Physiol (2002) 3.47
Selective incorporation of influenza virus RNA segments into virions. Proc Natl Acad Sci U S A (2003) 3.45
Host range restriction and pathogenicity in the context of influenza pandemic. Emerg Infect Dis (2006) 3.27
The lipid mediator protectin D1 inhibits influenza virus replication and improves severe influenza. Cell (2013) 3.19
Processing of ATG8s, ubiquitin-like proteins, and their deconjugation by ATG4s are essential for plant autophagy. Plant Cell (2004) 3.17
Emergence of influenza B viruses with reduced sensitivity to neuraminidase inhibitors. JAMA (2007) 3.00
Autophagy requires endoplasmic reticulum targeting of the PI3-kinase complex via Atg14L. J Cell Biol (2010) 2.98
The origins of new pandemic viruses: the acquisition of new host ranges by canine parvovirus and influenza A viruses. Annu Rev Microbiol (2005) 2.89
A single-amino-acid substitution in the NS1 protein changes the pathogenicity of H5N1 avian influenza viruses in mice. J Virol (2007) 2.80
Characterization of H5N1 influenza A viruses isolated during the 2003-2004 influenza outbreaks in Japan. Virology (2005) 2.77
Lower clinical effectiveness of oseltamivir against influenza B contrasted with influenza A infection in children. Clin Infect Dis (2006) 2.72
Hierarchy among viral RNA (vRNA) segments in their role in vRNA incorporation into influenza A virions. J Virol (2006) 2.70
Exploitation of nucleic acid packaging signals to generate a novel influenza virus-based vector stably expressing two foreign genes. J Virol (2003) 2.67
Identification of amino acids in HA and PB2 critical for the transmission of H5N1 avian influenza viruses in a mammalian host. PLoS Pathog (2009) 2.62
Contributions of two nuclear localization signals of influenza A virus nucleoprotein to viral replication. J Virol (2006) 2.60
Ebolavirus is internalized into host cells via macropinocytosis in a viral glycoprotein-dependent manner. PLoS Pathog (2010) 2.60
Reverse genetics demonstrates that proteolytic processing of the Ebola virus glycoprotein is not essential for replication in cell culture. J Virol (2002) 2.58
Human infection with highly pathogenic H5N1 influenza virus. Lancet (2008) 2.57
Enhanced expression of an alpha2,6-linked sialic acid on MDCK cells improves isolation of human influenza viruses and evaluation of their sensitivity to a neuraminidase inhibitor. J Clin Microbiol (2005) 2.55
Dynein-dependent movement of autophagosomes mediates efficient encounters with lysosomes. Cell Struct Funct (2008) 2.47
Importance of both the coding and the segment-specific noncoding regions of the influenza A virus NS segment for its efficient incorporation into virions. J Virol (2005) 2.45
Lethal influenza virus infection in macaques is associated with early dysregulation of inflammatory related genes. PLoS Pathog (2009) 2.44
Molecular determinants of Ebola virus virulence in mice. PLoS Pathog (2006) 2.44
Selection of H5N1 influenza virus PB2 during replication in humans. J Virol (2009) 2.42
Human macrophage C-type lectin specific for galactose and N-acetylgalactosamine promotes filovirus entry. J Virol (2004) 2.34